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SUPPLEMENTARY MATERIAL 
Supplementary Table 1: Variables collected as part of case-based HIV/AIDS surveillance in 
Europe - 2015 TESSy submission template* 
Variable type Variable Description Reporting 
System-related 
RecordID  Unique anonymous identifier Mandatory  
RecordType  
Structure and format of the data 
reported  
Mandatory  
RecordTypeVersion  
Version of the record type that defines 
the current structure of the data 
reported 
Optional  
Subject  
Disease associated with the reported 
case (HIV/AIDS for all cases) 
Mandatory  
Status  
Status is used for updating data; the 
default is New/Update. 
Optional  
DataSource  
Surveillance system from which the 
data on this particular disease 
originates 
Mandatory  
ReportingCountry  Country that reports the HIV case Mandatory  
DateUsedForStatistics  
Date used by the national surveillance 
organisation in HIV/AIDS case reporting 
and other official statistics 
Mandatory  
Diagnosis 
information  
DateOfDiagnosis  
Date of first HIV diagnosis; clinical or 
laboratory diagnosis 
Mandatory  
DateOfNotification  
Date on which the HIV case was 
notified to the reporting country 
Mandatory  
HIVType  Type of HIV infection Mandatory  
HIVStatus  
Status of HIV infection 
(prevpos=previously tested HIV 
positive) 
Optional  
Transmission  Most probable route of HIV exposure Mandatory  
TransmissionPartner  
Most probable route of HIV 
transmission of the partner 
Optional  
ProbableCountryOfInfection  
Country(ies) where infection of the 
patient is likely to have occurred 
Optional  
FirstCD4Count  CD4 cell count at time of diagnosis Mandatory  
FirstCD4Date  
Date of first CD4 cell count at time of 
diagnosis 
Mandatory  
AcuteInfection  Evidence of recent infection Optional  
Demographics  
Age  Age at diagnosis in years Mandatory  
Gender  Gender of the diagnosed person Mandatory  
CountryOfBirth  Country of birth of patient Mandatory  
RegionOfOrigin  Region from which the case originates Optional  
YearOfArrival  
Year patient arrived in the reporting 
country 
Optional  
Clinical 
information  
LastAttendanceDate  
Date the patient was last seen for HIV-
related care 
Optional  
ART  
Whether patient was on antiretroviral 
therapy (ART) at the date last seen for 
care 
Optional  
CD4Latest  Last known CD4 count Optional  
CD4LatestDate  Date of last CD4 count assessment Optional  
VLLatest  Last known viral load (VL) Optional  
VLLatestDate  Date of last known VL assessment Optional  
DateOfAIDSDiagnosis  Date of first AIDS diagnosis Optional  
AIDSIndicatorDisease  
AIDS indicator disease at the time of 
AIDS diagnosis occurring within two 
consecutive months from the date of 
AIDS diagnosis 
Optional  
Death  
DateOfDeath  Date of death due to any cause Mandatory  
DeathCause  
Information on whether the case is alive 
or deceased (due to AIDS-related and 
non-AIDS related causes) 
Mandatory  
*Adapted from ECDC and WHO Regional Office for Europe reporting protocol 2015 (9) 
Supplementary Table 2: Characteristics of adults diagnosed with HIV in the 31 included 
European countries by region, 2010-2014 
Variables 
Western 
Europe (n=14) 
Central 
Europe (n=9) 
Eastern 
Europe (n=8) 
n % n % n % 
Total 87,569 7,571 24,989 
Sex 
Men 62,780 72% 5,819 78% 15,301 61% 
Women 24,703 28% 1,603 22% 9,688 39% 
Age at 
diagnosis 
15-24 9,324 11% 1,561 21% 2,833 11% 
25-34 27,592 32% 2,964 40% 9,995 40% 
35-44 25,637 29% 1,766 24% 7,895 32% 
45-54 16,019 18% 708 10% 3,307 13% 
55-64 6,445 7% 311 4% 797 3% 
≥65 2,437 3% 82 1% 134 1% 
Diagnosis 
year 
2010 17,939 20% 1,134 15% 4,558 18% 
2011 17,945 20% 1,336 18% 4,760 19% 
2012 18,410 21% 1,555 21% 4,810 19% 
2013 17,394 20% 1,670 22% 4,996 20% 
2014 15,881 18% 1,876 25% 5,865 23% 
Exposure 
Sex between men 34,293 47% 2,730 43% 648 3% 
Heterosexual contact 34,896 47% 2,565 40% 15,406 65% 
Injecting drug use 3,757 5% 1,030 16% 7,573 32% 
Other 697 1% 9 0% 19 0% 
Region of 
origin 
Reporting country 34,081 51% 5,853 90% 20,515 85% 
Other Europe 7,596 11% 551 8% 3,618 15% 
Elsewhere 25,593 38% 81 1% 19 0% 
First CD4 
after 
diagnosis 
(cells/µL) 
<200 15,025 27% 1,732 33% 906 35% 
200-349 11,399 20% 970 18% 581 22% 
350-499 11,850 21% 954 18% 481 18% 
≥500 18,175 32% 1,625 30.8% 640 25% 
Completeness: sex 99.8% (n=119,894), age at diagnosis 99.7% (n= 119,807), year of diagnosis 100% (n=120,129), 
exposure 86.3% (n=103,623), region of diagnosis 100% (n=120,129), region of origin 81.5% (n=97,907) and CD4 count 
53.6% (n=64,338) 
Supplementary Table 3: Differences in demographics and diagnosis characteristics for 
those with and without reported CD4 and/or date data, 2010-2014 
Variables 
Total Missing CD4 data* 
CD4 count and 
date reported P value** 
N n % n % 
Total 120,129 52,187 67,942 - 
Sex 
Men 83,900 33,997 65% 49,903 74% 
<0.001 
Women 35,994 18,022 35% 17,972 26% 
Age at 
diagnosis 
15-24 13,718 5,573 11% 8,145 12% 
<0.001 
25-34 40,551 17,929 35% 22,622 33% 
35-44 35,298 15,573 30% 19,725 29% 
45-54 20,034 8,415 16% 11,619 17% 
55-64 7,553 3,145 6% 4,408 6% 
≥65 2,653 1,236 2% 1,417 2% 
Diagnosis 
year 
2010 23,631 10,608 20% 13,023 19% 
<0.001 
2011 24,041 10,692 20% 13,349 20% 
2012 24,775 10,922 21% 13,853 20% 
2013 24,060 10,233 20% 13,827 20% 
2014 23,622 9,732 19% 13,890 20% 
Region of 
diagnosis 
Western Europe 87,569 30,144 58% 57,425 85% 
<0.001 Central Europe 7,571 2,252 4% 5,319 8% 
Eastern Europe 24,989 19,791 38% 5,198 8% 
Exposure 
Sex between men 37,671 8,115 21% 29,556 46% 
<0.001 
Heterosexual contact 52,867 23,096 59% 29,771 46% 
Injecting drug use 12,360 7,923 20% 4,437 7% 
Other 725 225 1% 500 1% 
Region of 
origin 
Reporting country 60,449 26,711 70% 33,738 57% 
<0.001 Other Europe 11,765 4,615 12% 7,150 12% 
Elsewhere 25,693 6,945 18% 18,748 31% 
* People for whom the time between diagnosis and first CD4 count could not be calculated  -  including people missing a CD4 
count and date, those that had just CD4 date missing and for whom a partial date could not be calculated (year only) 
** Χ2 test for a difference in proportions             
Supplementary Table 4: Numerators and denominators used to calculate linkage to care in Europe by demographic and diagnosis 
characteristics by region, 2010-2014 
Variables 
Overall Western Europe Central Europe Eastern Europe 
n* N** N†  n* N** N†  n* N** N†  n* N** N†  
Total 57,565 60,030 104,796 50,804 52,571 77,975 4,469 4,950 6,858 2,292 2,509 19,963 
Sex 
Men 42,924 44,694 73,558 38,055 39,319 56,132 3,418 3,769 5,274 1,451 1,606 12,152 
Women 14,611 15,304 31,038 12,719 13,220 21,792 1,051 1,181 1,435 841 903 7,811 
Age at 
diagnosis 
15-24 7,070 7,491 12,315 5,771 6,044 8,491 1,039 1,161 1,475 260 286 2,349 
25-34 19,173 20,095 35,547 16,515 17,155 24,833 1,827 2,040 2,724 831 900 7,990 
35-44 16,540 17,183 30,598 14,858 15,328 22,829 1,015 1,104 1,565 667 751 6,204 
45-54 9,791 10,143 17,261 9,019 9,300 14,040 383 421 599 389 422 2,622 
55-64 3,800 3,898 6,509 3,514 3,595 5,609 164 178 248 122 125 652 
≥65 1,187 1,215 2,248 1,125 1,147 2,062 41 46 68 21 22 118 
Diagnosis 
year 
2010 10,894 11,381 20,944 10,198 10,603 16,267 590 667 1,055 106 111 3,622 
2011 11,257 11,816 20,913 10,477 10,873 16,001 702 821 1,164 78 122 3,748 
2012 11,760 12,248 21,408 10,638 10,995 16,207 945 1,067 1,433 177 186 3,768 
2013 11,729 12,137 20,542 10,134 10,397 14,967 1,056 1,143 1,517 539 597 4,058 
2014 11,925 12,448 20,989 9,357 9,703 14,533 1,176 1,252 1,689 1,392 1,493 4,767 
Exposure 
Sex between men 26,955 27,839 34,024 25,291 26,080 30,945 1,495 1,581 2,546 169 178 533 
Heterosexual contact 24,484 25,528 44,598 21,334 22,076 29,923 1,582 1,766 2,211 1,568 1,686 12,464 
Injecting drug use 2,790 3,103 9,857 1,590 1,693 3,032 748 875 956 452 535 5,868 
Other 382 419 626 376 412 602 4 4 6 2 3 18 
Region of 
origin 
Reporting country 27,508 28,772 50,812 21,969 22,651 29,271 4,038 4,502 5,246 1,501 1,619 16,295 
Other Europe 6,121 6,421 10,383 4,959 5,145 6,655 372 387 460 790 889 3,268 
Elsewhere 16,181 16,790 22,338 16,135 16,743 22,253 45 46 66 1 1 19 
First CD4 
after 
diagnosis 
(cells/µL) 
<200 15,528 16,063   13,423 13,740   1,359 1,505   746 818   
200-349 11,657 12,163   10,278 10,639   850 949   529 575   
350-499 12,020 12,549   10,753 11,151   831 920   436 478   
≥500 18,360 19,255   16,350 17,041   1,429 1,576   581 638   
* Numerator: number of people promptly linked 
** Denominator for main linkage calculation: number of people with a CD4 count and CD4 date after diagnosis 
† Denominator for lower bound calculation: number of people with either a CD4 count after diagnosis or missing CD4 data. People with partial (year only) diagnosis or CD4 date excluded. 
Supplementary Table 5: Proportion of people promptly linked to care by country and region 
of diagnosis, 2010-2014 
Region Country* 
Main 
estimate 
Lower 
bound† 
Western Europe 
Country 1 82% 80% 
Country 2 100% 57% 
Country 3 100% 69% 
Country 4 96% 55% 
Country 5 100% 63% 
Country 6 100% 2% 
Country 7 100% 71% 
Country 8 100% 89% 
Country 9 99% 13% 
Country 10 96% 84% 
Central Europe 
Country 1 100% 2% 
Country 2 99% 87% 
Country 3 96% 87% 
Country 4 97% 85% 
Country 5 84% 67% 
Country 6 87% 81% 
Country 7 96% 55% 
Country 8 94% 65% 
Eastern Europe 
Country 1 94% 77% 
Country 2 89% 33% 
Country 3 99% 6% 
Country 4 84% 24% 
Country 5 92% 11% 
* Countries have been anonymised with names and denominators 
removed 
† People without a CD4 count included in the denominator and 
considered not linked 
Supplementary Table 6: Factors associated with delayed linkage to care in Europe by region, 2010-2014 
    Western Europe Central Europe Eastern Europe 
Variables 
Adjusted odds ratio Adjusted odds ratio Adjusted odds ratio 
OR 95% CI P value* OR 95% CI P value* OR 95% CI P value* 
Sex 
Men 1.00 - - 1.00 - - 1.00 - - 
Women 1.00 0.86 - 1.17 0.988 0.97 0.74 - 1.28 0.849 0.95 0.65 - 1.38 0.781 
Age at 
diagnosis 
15-24 1.00 - - 1.00 - - 1.00 - - 
25-34 0.87 0.73 - 1.03 
0.012 
1.09 0.83 - 1.42 
0.870 
0.72 0.44 - 1.20 
0.036 
35-44 0.82 0.68 - 0.97 0.92 0.66 - 1.27 0.92 0.54 - 1.55 
45-54 0.88 0.72 - 1.08 0.91 0.57 - 1.46 0.58 0.32 - 1.06 
55-64 0.71 0.53 - 0.94 0.88 0.46 - 1.68 0.23 0.07 - 0.79 
≥65 0.45 0.26 - 0.79 1.01 0.29 - 3.44 0.60 0.08 - 4.78 
Diagnosis 
year 
2010 1.00 - - 1.00 - - 1.00 - - 
2011 0.93 0.79 - 1.09 
<0.001 
0.98 0.68 - 1.40 
<0.001 
13.83 5.17 - 36.95 
<0.001 
2012 0.82 0.70 - 0.97 0.82 0.58 - 1.16 1.27 0.41 - 3.92 
2013 0.66 0.55 - 0.79 0.53 0.37 - 0.77 1.56 0.58 - 4.19 
2014 1.03 0.88 - 1.21 0.50 0.34 - 0.72 1.43 0.56 - 3.69 
Exposure 
Sex between men 1.00 - - 1.00 - - 1.00 - - 
Heterosexual contact 1.22 1.05 - 1.43 
<0.001 
1.95 1.45 - 2.62 
<0.001 
1.85 0.88 - 3.93 
<0.001 
Injecting drug use 1.43 1.08 - 1.90 2.76 2.04 - 3.75 3.91 1.84 - 8.31 
Other 2.49 1.65 - 3.76 - - - 10.65 0.86 - 132.67 
Region of 
origin 
Reporting country 1.00 - - 1.00 - - 1.00 - - 
Other Europe 1.13 0.94 - 1.34 
0.073 
0.50 0.29 - 0.86 <0.001 1.95 1.35 - 2.82 <0.001 
Elsewhere 1.14 1.01 - 1.32 - - - - - - 
First CD4 
after 
diagnosis 
(cells/µL) 
<200 1.00 - - 1.00 - - 1.00 - - 
200-349 1.40 1.18 - 1.67 
<0.001 
1.11 0.81 - 1.51 
0.784 
0.97 0.64 - 1.48 
0.738 
350-499 1.57 1.32 - 1.87 1.15 0.84 - 1.57 1.12 0.73 - 1.74 
≥500 1.87 1.60 - 2.19 1.01 0.77 - 1.34 1.21 0.81 - 1.82 
*Likelihood ratio test 
Grey shading indicates a lack of data  or very small cell counts 
 
